Locust Bioventures
Our Mission
Transforming Discoveries from Penn Labs into Successful Biotech Spinouts
As a student group at the University of Pennsylvania, we bridge the gap between discovery and biotech venture creation at Penn. Our team of undergraduates conduct market research, financial modeling, and due diligence to provide researchers with the materials and analysis needed to spinout successful biotech companies.
Past Projects
Cerespectus
(Spring 2023)
Catheters for precise gene therapy delivery and treatment of central nervous system disorders
Founded by: Bryan Pukenas, MD
PhylloPharma
(Fall 2022)
Drug delivery platform for genetically engineered plants containing ACE2 inhibitors for SARS-CoV-2
Founded by: Henry Daniell, PhD
Vellum Biosciences
(Fall 2021)
Non-invasive imaging diagnostic to differentiate cancer, inflammation, and infection
Founded by: Mark Sellmyer, MD, PhD & Robert Mach, PhD
Ribovate Therapeutics
(Spring 2021)
Next generation targeted mRNA-lipid nanoparticle therapeutic platform for gene therapy and oncology
Founded by: Drew Weissman, MD, PhD & Hamideh Parhiz, PharmD, PhD
Carousel Therapeutics
(Spring 2021)
A switchable CAR-T platform to prevent antigen loss in cancer treatment
CARTIO
(Fall 2020)
CAR regulatory T cells to treat atherosclerosis and other cardiovascular diseases
Founded by: Robert Schwab, MD, MS
Partners
Space
locustbioventures.com 